SLFN11 Human Pre-designed siRNA Set A contains three designed siRNAs for SLFN11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLFN12 Human Pre-designed siRNA Set A contains three designed siRNAs for SLFN12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLFN12L Human Pre-designed siRNA Set A contains three designed siRNAs for SLFN12L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLFN13 Human Pre-designed siRNA Set A contains three designed siRNAs for SLFN13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLFN14 Human Pre-designed siRNA Set A contains three designed siRNAs for SLFN14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLFN5 Human Pre-designed siRNA Set A contains three designed siRNAs for SLFN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLIRP Human Pre-designed siRNA Set A contains three designed siRNAs for SLIRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLIT1 Human Pre-designed siRNA Set A contains three designed siRNAs for SLIT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLIT2 Human Pre-designed siRNA Set A contains three designed siRNAs for SLIT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLIT3 Human Pre-designed siRNA Set A contains three designed siRNAs for SLIT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLITRK1 Human Pre-designed siRNA Set A contains three designed siRNAs for SLITRK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLITRK2 Human Pre-designed siRNA Set A contains three designed siRNAs for SLITRK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLITRK3 Human Pre-designed siRNA Set A contains three designed siRNAs for SLITRK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLITRK4 Human Pre-designed siRNA Set A contains three designed siRNAs for SLITRK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLITRK5 Human Pre-designed siRNA Set A contains three designed siRNAs for SLITRK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLITRK6 Human Pre-designed siRNA Set A contains three designed siRNAs for SLITRK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLK Human Pre-designed siRNA Set A contains three designed siRNAs for SLK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLMAP Human Pre-designed siRNA Set A contains three designed siRNAs for SLMAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLN Human Pre-designed siRNA Set A contains three designed siRNAs for SLN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLPI Human Pre-designed siRNA Set A contains three designed siRNAs for SLPI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLTM Human Pre-designed siRNA Set A contains three designed siRNAs for SLTM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLU7 Human Pre-designed siRNA Set A contains three designed siRNAs for SLU7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLURP1 Human Pre-designed siRNA Set A contains three designed siRNAs for SLURP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLURP2 Human Pre-designed siRNA Set A contains three designed siRNAs for SLURP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLX1A Human Pre-designed siRNA Set A contains three designed siRNAs for SLX1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLX1B Human Pre-designed siRNA Set A contains three designed siRNAs for SLX1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLX4 Human Pre-designed siRNA Set A contains three designed siRNAs for SLX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLX4IP Human Pre-designed siRNA Set A contains three designed siRNAs for SLX4IP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLX9 Human Pre-designed siRNA Set A contains three designed siRNAs for SLX9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SM27 (NSC 37204) is an inhibitor for fibroblast growth factors (FGF). SM27 inhibits angiogenesis through block of FGF2/HSPGs/FGFR1 complex formation[1].

SMAD1 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAD2 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Smad2/3-IN-2 (Compound 3) is an inhibitor for TGF-β-dependent Smad2/3 and IL-4-dependent STAT6 signaling pathway, with IC50s of 90 and 20 nM, respectively[1].

Smad2/3-IN-2 (Compound 3) is an inhibitor for TGF-β-dependent Smad2/3 and IL-4-dependent STAT6 signaling pathway, with IC50s of 90 and 20 nM, respectively[1].

SMAD3 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAD4 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAD5 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAD6 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAD7 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAD9 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAD9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAGP Human Pre-designed siRNA Set A contains three designed siRNAs for SMAGP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for SMAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMARCA1 Human Pre-designed siRNA Set A contains three designed siRNAs for SMARCA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMARCA2 Human Pre-designed siRNA Set A contains three designed siRNAs for SMARCA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SMARCA4 Human Pre-designed siRNA Set A contains three designed siRNAs for SMARCA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.